James R. Gavin, III, MD, PhD, discusses the pharmacokinetics behind the long duration of action of Tresiba®, and what it means for patients with diabetes.
James R. Gavin, III, MD, PhD, discusses the pharmacokinetics behind the long duration of action of Tresiba®, and what it means for patients with diabetes.
James R. Gavin, III, MD, PhD, discusses the pharmacokinetics behind the long duration of action of Tresiba®, and what it means for patients with diabetes.
Tresiba® (insulin degludec injection) is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba® is not recommended for treating diabetic ketoacidosis.